NL-OMON43135
Withdrawn
Not Applicable
InTerlaboratory Evaluation of a GastroIntestinal Activity Ergometertest in Non-intense Trained PersOns - TEMPO!
Hogeschool Utrecht0 sites16 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- gastrointestinal activity
- Sponsor
- Hogeschool Utrecht
- Enrollment
- 16
- Status
- Withdrawn
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Generally healthy
- •Recreational athlete with at least two years of cycling experience of at least twice a week
- •18\-35 years old
- •Meeting criteria of valid max\-test
- •Body mass index (BMI) 20\-25 kg/m2
- •Veins suitable for blood sampling at inspection
Exclusion Criteria
- •\-Known symptoms of immune diseases such as diabetes, celiac disease, gastric disease
- •\-Known symptoms of intestinal diseases such as Crohn\*s disease, colitis ulcerosa, irritable bowel syndrome fibrosis
- •\-Use of hard drugs
- •\-\-Chronic use of NSAIDs: aspirin, ibuprofen, etc.
- •\-Drugs for gastric and/or intestinal function
- •\- Participation in other scientific studies
- •\-Blood donation during the last six weeks prior to the start of the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
InTerlaboratory Evaluation of a GastroIntestinal Activity ErgoMeterTest in Non-intense Trained PersOnsgastrointestinal activitygastrointestinal function10017947NL-OMON45536Hogeschool Utrecht16
Not yet recruiting
Not Applicable
A clinical trial to evaluate to GastroIntestinal protective eFfect of Tegoprazan for utilization of potent P2Y12 inhibitors in patients with Acute Coronary Syndrome (GIFT-ACS trial)Diseases of the circulatory systemKCT0007897Yonsei University Yongin Severance Hospital124
Recruiting
Phase 3
Extracorporeal magnetic navigation system of capsule endoscopyGastrointestinal Malignant Tumor, Gastric or Duodenal Ulcer, Gastrointestinal Bleeding,Gastrointestinal Benign Tumor, Inflammatory Bowel Disease, Gastrointestinal screeningJPRN-jRCT1092220114Hidetoshi Ohta40
Recruiting
Not Applicable
The study of assessment for gastrointestinal motility function using radiopaque markercolorectal cancerJPRN-UMIN000005297ippon Medical School Department of surgery100
Active, not recruiting
Phase 1
A new way of evaluating the adverse effects of opioids on the gut.Opioid-induced bowel dysfunction.MedDRA version: 18.0Level: LLTClassification code 10071128Term: Opioid induced constipationSystem Organ Class: 100000004856Therapeutic area: Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]EUCTR2013-001540-60-DKMech-Sense, Aalborg University Hospital